JDRF (formerly known as the Juvenile Diabetes Research Foundation) is a major charitable 501(c)(3) organization dedicated to funding type 1 diabetes research (T1D). JDRF’s stated goal is to “progressively remove the impact of T1D from people’s lives until we achieve a world without T1D.”

JDRF uses over 80% of its expenditures to support research and research-related education.”

The organization has its executive office in New York City, with chapters and branches throughout the U.S., and international affiliates in Australia, Canada, Denmark, Germany, Israel, Mexico, the Netherlands, and the United Kingdom.

Learn more about  JDRF

united-way-smallUnited Way Worldwide is the leadership and support organization for the network of nearly 1,800 community-based United Ways in 45 countries and territories. We envision a world where all individuals and families achieve their human potential through educationincome stability and healthy lives. To advance the common good and mobilize the caring power of communities around the world, we will:

  • Ignite a worldwide social movement, and thereby mobilize millions to action — to giveadvocate and volunteer to improve the conditions in which they live;
  • Galvanize and connect all sectors of society — individuals, businesses, non-profit organizations and governments — to create long-term social change that produces healthy, well-educated and financially-stable individuals and families;
  • Raise, invest and leverage billions of dollars annually in philanthropic contributions to create and support innovative programs and approaches to generate sustained impact in local communities; and
  • Hold ourselves accountable to this cause through our steadfast commitment to continually measure — in real terms — improvements in education, income and health.

Learn More about United Way


Memorial Sloan Kettering Cancer Center — the world’s oldest and largest private cancer center — has devoted more than 130 years to exceptional patient care, innovative research, and outstanding educational programs. Today, we are one of 41 National Cancer Institute–designated Comprehensive Cancer Centers, with state-of-the-art science flourishing side by side with clinical studies and treatment.

The close collaboration between our physicians and scientists is one of our unique strengths, enabling us to provide patients with the best care available as we work to discover more-effective strategies to prevent, control, and ultimately cure cancer in the future. Our education programs train future physicians and scientists, and the knowledge and experience they gain at Memorial Sloan Kettering has an impact on cancer treatment and biomedical research around the world.

Learn more about Memorial Sloan Kettering.